市場調查報告書
商品編碼
1541088
2024-2032 年按技術(三重四極桿、四極桿 TOF、FTMS、四極桿、飛行時間、離子阱等)、應用和區域分類的質譜市場報告Mass Spectrometry Market Report by Technology (Triple Quadrupole, Quadrupole TOF, FTMS, Quadrupole, Time-of-Flight, ION Trap, and Others), Application, and Region 2024-2032 |
2023 年,全球質譜IMARC Group規模達到 65 億美元。最近的技術進步、嚴格的品質控制監管政策、對個人化醫療的日益關注以及公共和私營部門研發(R&D)資金的增加是推動市場的一些主要因素。
質譜法是指用於測量離子質荷比的分析技術。它包括氣相層析質譜 (GC-MS)、基質輔助雷射解吸/電離 (MALDI) 和液相層析質譜 (LC-MS)。質譜分析具有許多特性,例如高靈敏度、特異性和寬動態範圍。它廣泛應用於藥物發現、環境監測、法醫學、食品安全、臨床診斷、蛋白質體學、石油探勘和材料科學。質譜分析提供高通量能力、分析的多功能性以及與其他多維分析技術的兼容性。
公共和私營部門的研發(R&D)資金不斷增加,為購買先進的質譜系統提供了財政支持,推動了市場的成長。此外,人們對環境污染的日益關注需要對空氣和水樣本進行分析,這也是另一個促進成長的因素。此外,法醫學的不斷發展,加上刑事調查中對物質分析的迫切需求,正在促進市場的成長。除此之外,新興的代謝組學領域(涉及生物樣本中代謝物的詳細分析)正在促進市場成長。除此之外,在各種科學探索的學術研究中採用質譜分析正在促進市場成長。此外,技術融合,即質譜法與色譜法等其他技術相結合,從而擴大了其適用性,正在加強市場成長。
最近的技術進步
技術進步的激增極大地促進了質譜市場的擴張。尖端的改進,例如更高的靈敏度、更好的準確性和快速的通量,使這些儀器在現代實驗室中不可或缺。此外,技術進步正在擴展質譜儀器的能力,以包括對日益複雜的樣品的分析。此外,高解析度質譜和串聯質譜等最新創新提供了前所未有的細節水平和分析深度,支持了市場的成長。此外,即時監控功能的結合,允許立即收集和解釋資料,正在加強市場成長。此外,質譜設備的小型化導致了可用於現場分析的攜帶式設備的誕生,有利於市場的成長。
實施嚴格的品質管制監管政策
製藥和食品安全等行業品質控制的監管要求正在推動質譜市場的成長。監管機構引入嚴格的標準促使公司依賴質譜法來檢測雜質、確保產品品質和驗證工藝,因為質譜法具有高精度和高靈敏度。此外,質譜可確保化合物符合純度標準,並在極低濃度下檢測到污染物。此外,食品業廣泛利用技術來確保不含農藥、毒素和其他污染物,這有利於市場成長。此外,這些監管強制要求使得質譜分析不僅是一種選擇,而且是產品開發和製造過程中品質保證的必需品。
對個人化醫療的日益關注
對個人化醫療的日益重視是刺激質譜市場的另一個關鍵因素。醫療保健越來越適合個別患者,從而對詳細的分子和遺傳資訊提出了更高的需求。質譜分析提供了在分子層面分析生物標記、代謝物和蛋白質的能力,從而在蛋白質體學和基因組學研究中發揮重要作用。這些見解對於了解個人健康狀況、預測疾病易感性並相應調整治療方案至關重要。此外,個人化醫療的興起正在推動醫療保健提供者和研究機構投資質譜技術,以滿足對精確、患者特定資料的需求。因此,對個人化醫療保健的關注不僅促進了質譜在現有市場的應用,而且還開創了其進入醫學科學新領域的先河。
The global mass spectrometry market size reached US$ 6.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032. The recent technological advancements, imposition of strict regulatory policies for quality control, growing focus on personalized medicine, and escalating funding for research and development (R&D) in both public and private sector are some of the major factors propelling the market.
Mass spectrometry refers to an analytical technique used to measure the mass-to-charge ratio of ions. It includes gas chromatography-mass spectrometry (GC-MS), matrix-assisted laser desorption/ionization (MALDI), and liquid chromatography-mass spectrometry (LC-MS). Mass spectrometry offers numerous features, such as high sensitivity, specificity, and a broad dynamic range. It is widely used in drug discovery, environmental monitoring, forensics, food safety, clinical diagnostics, proteomics, petroleum exploration, and materials science. Mass spectrometry offers high-throughput capabilities, versatility in analysis, and compatibility with other techniques for multidimensional analysis.
The escalating funding for research and development (R&D) in both public and private sectors, which is providing financial support for acquiring advanced mass spectrometry systems is propelling the market growth. Additionally, the growing concerns about environmental pollution that are necessitating the analysis of air and water samples are acting as another growth-inducing factor. Furthermore, the rising expansion of forensic science, coupled with the urgent requirement for substance analysis in criminal investigations, is contributing to the market growth. Besides this, the burgeoning field of metabolomics, which involves the detailed analysis of metabolites in biological samples, is bolstering the market growth. Apart from this, the adoption of mass spectrometry in academic research for various scientific explorations is catalyzing the market growth. Moreover, technological convergence, where mass spectrometry is being integrated with other techniques like chromatography, thus expanding its applicability, is strengthening the market growth.
The recent technological advancements
The surge in technological advancements is significantly contributing to the expansion of the mass spectrometry market. Cutting-edge improvements, such as higher sensitivity, better accuracy, and rapid throughput are making these instruments indispensable in modern laboratories. Furthermore, technological progress is expanding the capabilities of mass spectrometry instruments to include the analysis of increasingly complex samples. Additionally, recent innovations like high-resolution mass spectrometry and tandem mass spectrometry that are providing unprecedented levels of detail and analytical depth are supporting the market growth. Moreover, the incorporation of real-time monitoring capabilities, allowing immediate data collection and interpretation, is strengthening the market growth. In addition, the miniaturization of mass spectrometry devices, leading to the creation of portable units that can be employed for on-site analysis, is favoring the market growth.
The imposition of strict regulatory policies for quality control
Regulatory requirements for quality control in industries, such as pharmaceuticals and food safety are propelling the mass spectrometry market growth. The introduction of stringent standards by regulatory agencies is prompting companies to rely on mass spectrometry for its high degree of accuracy and sensitivity in detecting impurities, ensuring product quality, and validating processes. In addition, mass spectrometry ensures that compounds meet purity standards and that contaminants are detected at extremely low concentrations. Furthermore, the widespread technology utilization in the food industry to ensure the absence of pesticides, toxins, and other contaminants is favoring the market growth. Moreover, these regulatory compulsions make mass spectrometry not just an option but a necessity for quality assurance in product development and manufacturing processes.
The growing focus on personalized medicine
The growing emphasis on personalized medicine is another pivotal factor stimulating the mass spectrometry market. Healthcare is becoming increasingly tailored to individual patients, resulting in a higher demand for detailed molecular and genetic information. Mass spectrometry provides the capability to analyze biomarkers, metabolites, and proteins at a molecular level, thereby playing a significant role in proteomics and genomics research. These insights are crucial for understanding individual health profiles, predicting disease susceptibility, and tailoring treatments accordingly. Furthermore, the rise in personalized medicine is pushing healthcare providers and research institutions to invest in mass spectrometry technologies to keep up with the demand for precise, patient-specific data. As a result, the focus on personalized healthcare is not only boosting the application of mass spectrometry in existing markets but is also pioneering its entry into new avenues of medical science.
IMARC Group provides an analysis of the key trends in each segment of the global mass spectrometry market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on technology and application.
Triple Quadrupole (Tandem)
Quadrupole TOF (Q-TOF)
FTMS (Fourier Transform Mass Spectrometry)
Quadrupole
Time-of-Flight (TOF)
ION Trap
Others
Triple quadrupole (tandem) dominates the market
The report has provided a detailed breakup and analysis of the market based on technology. This includes triple quadrupole (Tandem), quadrupole TOF (Q-TOF), FTMS (fourier transform mass spectrometry), quadrupole, time-of-flight (TOF), ION trap, and others. According to the report, triple quadrupole (tandem) represented the largest segment.
Triple quadrupole systems offer high sensitivity and selectivity, making them ideal for detecting low-abundance analytes in complex samples. Furthermore, they are versatile and can be applied to various fields, such as proteomics, metabolomics, pharmaceuticals, and environmental analysis. This multi-disciplinary application range contributes to their widespread adoption. Besides this, triple quadrupole mass spectrometers excel in quantitative measurements, as they provide excellent repeatability and accuracy, which are crucial in sectors like drug development and diagnostics. Additionally, these systems are often compatible with various ionization techniques and chromatography systems, allowing for broader applications and easier integration into existing workflows. Moreover, triple quadrupole meets or exceeds the stringent regulations and quality standards required in many industries, which makes them a safer investment for compliance-conscious organizations.
Pharmaceuticals
Biotechnology
Chemical and Petrochemicals
Environmental Testing
Food & Beverage Testing
Others
Pharmaceutical hold the largest share in the market
A detailed breakup and analysis of the market based on application has also been provided in the report. This includes pharmaceuticals, biotechnology, chemical and petrochemicals, environmental testing, food & beverage testing, and others. According to the report, pharmaceuticals represented the largest segment.
Pharmaceuticals are dominating the market as it is governed by strict regulatory standards. In line with this, mass spectrometry is invaluable for quality control and compliance, ensuring that pharmaceutical products meet these rigorous benchmarks. Furthermore, mass spectrometry is critical in the various stages of drug discovery, including target identification, screening, and pharmacokinetics. It provides accurate and precise data that aid researchers in the identification and quantification of compounds, thereby accelerating the time-to-market for new drugs. Besides this, mass spectrometry offers the high sensitivity and specificity required for proteomic and genomic studies, thereby driving its adoption in the pharmaceutical sector. Additionally, it is extensively used in metabolomics to identify and quantify metabolites, thus offering valuable insights into drug metabolism. Moreover, mass spectrometry is routinely used for quality control and batch-to-batch verification of raw materials, intermediates, and finished products.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest mass spectrometry market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America hosts some of the world's leading research institutions and laboratories, which contributes to a high demand for mass spectrometry equipment for advanced research. Additionally, various government agencies are offering substantial grants and funding options for research and development (R&D) activities, including those that require mass spectrometry, thus fostering a favorable environment for market growth. Besides this, North America is the headquarters for numerous companies that are market leaders in the mass spectrometry segment. Moreover, the region is at the forefront of technological innovation in advanced mass spectrometry techniques like time-of-flight (TOF) and orbitrap. In addition to this, the presence of a robust healthcare system, coupled with the focus on precision medicine and diagnostics in the region, is further boosting the market growth.
Top companies are developing new technologies and improving existing mass spectrometry techniques. This includes creating instruments that are faster, more sensitive, and easier to use. Furthermore, they are engaging in acquisitions and mergers to diversify their portfolio, enter into new markets, and strengthen their presence. Apart from this, leading players are partnering with research institutions, laboratories, or other firms to share expertise and resources, which enables them to bring products to market more quickly and to tackle problems from multiple angles. Besides this, companies are also working to ensure that their products meet strict regulatory standards, both locally and globally. It involves clinical trials, rigorous testing, and obtaining necessary certifications. Moreover, major players are offering robust customer service, including training programs to educate users on how to get the most out of their mass spectrometry equipment.
Agilent Technologies Inc.
Bruker
Danaher Corporation
JEOL Ltd.
Kore Technology Ltd.
LECO Corporation
PerkinElmer Inc.
Rigaku Corporation
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Waters Corporation
In June 2022, Agilent Technologies Inc. announced the launch of new quadrupole mass spectrometers at the ASMS conference on mass spectrometry and allied topics.
In June 2023, Bruker launched the timsTOF ultra mass spectrometer with transformative sensitivity.
In February 2021, JEOL announced the launch of new time-of-flight mass spectrometers with improved performance and functionality.